Braeburn Overview
- Founded
- 2012
- Status
- Private
- Employees
- 64
- Latest Deal Type
- Debt - PPP
- Financing Rounds
- 5
- Investments
- 2
Braeburn General Information
Description
Provider of medications intended for people living with the serious and fatal consequences of opioid use disorder. The company is committed to advancing a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, enabling patients, healthcare professionals and society to address the escalating disease burden of addiction.
Contact Information
Website
www.braeburnrx.com
Formerly Known As
AT Pharmaceuticals, Braeburn Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
- 450 Plymouth Road
- Suite 400
- Plymouth Meeting, PA 19462
- United States
+1 (610) 000-0000
Braeburn Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Braeburn‘s full profile, request access.
Request a free trialBraeburn Patents
Braeburn Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10457113-B2 | Vehicle extreme temperature safety systems and methods | Active | 27-Feb-2015 | 00000000000 | |
| US-20170028811-A1 | Vehicle extreme temperature safety systems | Granted | 27-Feb-2015 | 00000000000 | 0 |
Braeburn Executive Team (15)
Braeburn Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000000 00.0 | Self | Board Member | 000 0000 |
| 00000 00000000 | Avista Capital Partners | Board Member | 000 0000 |
| 000000 000000 00 | Self | Board Member | 000 0000 |
| 0000 0000000 | Braeburn | Chief Executive Officer, President & Director of the Board | 000 0000 |
| 0000000 0000000 | Self | Board Member | 000 0000 |
Braeburn Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBraeburn Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Braeburn‘s full profile, request access.
Request a free trialBraeburn Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 01-May-2015 | 000000000 | Buildings and Property | ||
| Titan Pharmaceuticals | 13-Nov-2013 | PIPE | 000 | Biotechnology |
Braeburn Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000 000000000000 | 13-Nov-2013 | 0000 | 000 | Completed |
|